Sibylle C. Mellinghoff
- Infectious Diseases top 2%
- Epidemiology top 5%
- Oncology top 10%
- Immunology
- Health top 10%
- Co-authors
- Oliver A. CornelyPhilipp KoehlerJon Salmanton‐GarcíaEnrico SchalkMarcus HentrichMarie von Lilienfeld‐ToalGeorg MaschmeyerDieter Buchheidt
- Topics
- Antifungal resistance and susceptibility (22 papers)Fungal Infections and Studies (17 papers)SARS-CoV-2 and COVID-19 Research (11 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Sibylle C. Mellinghoff
47 papers receiving 987 citations
Peers
Comparison fields: 5 of 93
- Infectious Diseases 585
- Epidemiology 477
- Oncology 251
- Immunology 99
- Health 85
Countries citing papers authored by Sibylle C. Mellinghoff
This map shows the geographic impact of Sibylle C. Mellinghoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibylle C. Mellinghoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibylle C. Mellinghoff more than expected).
Fields of papers citing papers by Sibylle C. Mellinghoff
This network shows the impact of papers produced by Sibylle C. Mellinghoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibylle C. Mellinghoff. The network helps show where Sibylle C. Mellinghoff may publish in the future.
Co-authorship network of co-authors of Sibylle C. Mellinghoff
This figure shows the co-authorship network connecting the top 25 collaborators of Sibylle C. Mellinghoff. A scholar is included among the top collaborators of Sibylle C. Mellinghoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibylle C. Mellinghoff. Sibylle C. Mellinghoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 25 | |
| 12 | 3 | |
| 13 | 0 | |
| 14 | 31 | |
| 15 | 68 | |
| 16 | 78 | |
| 17 | 100 | |
| 18 | 11 | |
| 19 | 117 | |
| 20 | 31 |
About Sibylle C. Mellinghoff
Sibylle C. Mellinghoff is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology, having authored 56 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (17 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). The work is most often cited by research in Infectious Diseases (585 citations), Applied Microbiology and Biotechnology (48 citations) and Epidemiology (477 citations). Sibylle C. Mellinghoff has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Oliver A. Cornely, Philipp Koehler, Jon Salmanton‐García, Enrico Schalk, Marcus Hentrich, Marie von Lilienfeld‐Toal, Georg Maschmeyer, Dieter Buchheidt, Michael von Bergwelt‐Baildon and Tomás Franquet. Their work appears in journals such as Blood, Cochrane Database of Systematic Reviews and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.